Relationship Between Serum N/OFQ and Brain-heart Syndrome
NCT ID: NCT05344794
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2023-05-01
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Infection After Ischemic Stroke
NCT05923034
Molecular Network Characteristics of Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics Integrated Analysis
NCT05626296
Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults
NCT05113043
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke
NCT06470477
The Biological Basis of Phlegm Dampness Syndrome in Patients With Ischemic Strokeļ¼A Saliva and Urine Proteomics Study
NCT04472754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CCS group
Patients with cerebral syndrome diagnosed by the Second Hospital of Shanxi Medical University
Enzyme-linked immunosorbent assay
Serum N/OFQ , IL-6 and NE levels were detected.
Control group
Patients who have not had a cerebral syndrome in ischemic stroke
Enzyme-linked immunosorbent assay
Serum N/OFQ , IL-6 and NE levels were detected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enzyme-linked immunosorbent assay
Serum N/OFQ , IL-6 and NE levels were detected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute ischemic stroke patients in line with the "Chinese Acute Ischemic Stroke Treatment Guide 2018" related diagnostic criteria
* There is no intimate relationship between all selected people and knows this study, and signs informed consent
Exclusion Criteria
* Complicated with severe cardiovascular complications (such as coronary heart disease, acute coronary syndrome, acute myocardial infarction, chronic heart failure, atrial fibrillation, etc.)
* Complicated with severe liver and kidney dysfunction (such as coagulous dysfunction, cirrhosis, nephrotic syndrome , Renal failure, etc.)
* Complicated with severe diabetes complications (such as diabetic nephropathy, diabetic foot, diabetic acidosis, high blood sugar hypertonic state, diabetes coronary heart disease, etc.)
* Complicated with Psychological disease
* Complicated with chronic obstructive pulmonary disease(COPD)
* BMI\> 40
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zheng Guo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zheng Guo
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second of Shanxi Medical University
Taiyuan, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
hanyi20220418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.